Stock Information
Evolus Inc (EOLS)
Ticker Symbol: EOLS
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $416.20 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -0.6704
Revenue (TTM): $4.63 M
Dividend Yield: N/A%
ROE: -410.18%
Latest News
-
Evolus, Inc. Launches Estyme Injectable Hyaluronic Acid Gels Collection in Europe
Mon, May 11, 2026 11:51 AM
-
Evolus announces commercial launch of Estyme® injectable hyaluronic acid gels in Europe
Mon, May 11, 2026 9:31 AM
Key Financials
Financial data not available